E-LIB Suche - Ergebnisse für: Morgenstern, Daniel A

1

How we approach early phase clinical trial and off-label th..:

Revon-Rivière, Gabriel ; Tibout, Pauline ; Cabral, Jennifer...
EJC Paediatric Oncology. 3 (2024) - p. 100154 , 2024

Link: https://doi.org/10.1016/..

2

IMMU-07. COMBINED PD1 AND LAG3 INHIBITION IN PRECLINICAL MO..:

Das, Anirban ; Crump, Owen ; Kos, Olha...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

3

Access to innovative therapies in pediatric oncology: Repor..:

Judd, Sandra ; Revon‐Riviere, Gabriel ; Grover, Stephanie A....
Cancer Medicine. 13 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

4

TRLS-08. ROVER: A PHASE 1/2 TRIAL IN PROGRESS OF AVAPRITINI..:

Abbou, Samuel ; Koschmann, Carl ; Kramm, Christof M...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

5

131-I-MIBG therapy in combination with PARP inhibitors for ..:

Cohen-Gogo, Sarah ; Shammas, Amer ; Shlien, Adam..
EJC Paediatric Oncology. 3 (2024) - p. 100152 , 2024

Link: https://doi.org/10.1016/..

6

TRLS-10. ROVER: A PHASE 1/2 STUDY OF AVAPRITINIB IN PEDIATR..:

Koschmann, Carl ; Hoffman, Lindsey M ; Kramm, Christof M...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i81-i81 , 2023

Link: https://doi.org/10.1093/..

7

IMMU-08. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEF..:

Das, Anirban ; Fernandez, Nicholas R ; Levine, Adrian...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i50-i51 , 2023

Link: https://doi.org/10.1093/..

8

Renal Implications of Long-Term Systemic Bevacizumab for Re..:

Robinson, Cal H. ; Hart-Matyas, Michael ; Morgenstern, Daniel A...
Annals of Otology, Rhinology & Laryngology. 133 (2023) 1 - p. 119-123 , 2023

Link: https://doi.org/10.1177/..

9

IMMU-24. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEF..:

Das, Anirban ; Fernandez, Nicholas ; Levine, Adrian...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v147-v147 , 2023

Link: https://doi.org/10.1093/..

10

Lorlatinib with or without chemotherapy in ALK-driven refra..:

Goldsmith, Kelly C. ; Park, Julie R. ; Kayser, Kimberly...
Nature Medicine. 29 (2023) 5 - p. 1092-1102 , 2023

Link: https://doi.org/10.1038/..

11

Pain mitigation and management strategies for anti‐GD2 infu..:

Nysom, Karsten ; Morad, Andrea Gomez ; Rafael, Margarida Simão...
Pediatric Blood & Cancer. 70 (2023) 5 - p. , 2023

Link: https://doi.org/10.1002/..

12

Ensuring access to innovative therapies for children, adole..:

Revon-Riviere, Gabriel ; Young, Leah C ; Stephenson, Elizabeth A...
Paediatrics & Child Health. 28 (2023) 7 - p. 399-403 , 2023

Link: https://doi.org/10.1093/..

13

Efficacy of Nivolumab in Pediatric Cancers with High Mutati..:

Das, Anirban ; Tabori, Uri ; Sambira Nahum, Lauren C....
Clinical Cancer Research. 29 (2023) 23 - p. 4770-4783 , 2023

Link: https://doi.org/10.1158/..

14

Precision oncology for children: A primer for paediatrician:

Cohen-Gogo, Sarah ; Denburg, Avram E ; Villani, Anita...
Paediatrics & Child Health. 28 (2023) 5 - p. 278-284 , 2023

Link: https://doi.org/10.1093/..

15

Genomic predictors of response to PD-1 inhibition in childr..:

Das, Anirban ; Sudhaman, Sumedha ; Morgenstern, Daniel...
Nature Medicine. 28 (2022) 1 - p. 125-135 , 2022

Link: https://doi.org/10.1038/..